{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:41:20Z","timestamp":1775018480185,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","mayoclinicproceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.mayocp.2016.01.002","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T10:15:29Z","timestamp":1456827329000},"page":"279-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["The Natural History of Nonobstructive Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"91","author":[{"given":"Virginia B.","family":"Hebl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin C.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David O.","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Martijn","family":"Bos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle W.","family":"Klarich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rick A.","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard J.","family":"Gersh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve R.","family":"Ommen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey B.","family":"Geske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 4","key":"10.1016\/j.mayocp.2016.01.002_bib1","first-page":"3","article-title":"Idiopathic hypertrophic subaortic stenosis, I: a description of the disease based upon an analysis of 64 patients","volume":"30","author":"Braunwald","year":"1964","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mayocp.2016.01.002_bib2","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/j.jtcvs.2011.10.020","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"142","author":"Gersh","year":"2011","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.mayocp.2016.01.002_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.mayocp.2016.01.002_bib4","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2004.12.067","article-title":"The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms","volume":"45","author":"Autore","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.mayocp.2016.01.002_bib5","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.mayocp.2016.01.002_bib6","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/hrt.2007.126003","article-title":"Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy","volume":"94","author":"Shah","year":"2008","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.mayocp.2016.01.002_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0002-9149(91)90450-Y","article-title":"Prognosis of nonobstructive hypertrophic cardiomyopathy","volume":"67","author":"Aron","year":"1991","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2016.01.002_bib8","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jtcvs.2009.07.079","article-title":"Apical myectomy: a new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy","volume":"139","author":"Schaff","year":"2010","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.mayocp.2016.01.002_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.echo.2011.03.006","volume":"24","author":"Nagueh","year":"2011","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"6","key":"10.1016\/j.mayocp.2016.01.002_bib10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0025-6196(11)61527-9","article-title":"Yield of genetic testing in hypertrophic cardiomyopathy","volume":"80","author":"Van Driest","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.mayocp.2016.01.002_bib11","series-title":"Expected Survival Based on Hazard Rates(Update)","author":"Therneau","year":"1999"},{"issue":"7","key":"10.1016\/j.mayocp.2016.01.002_bib12","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients","volume":"36","author":"Elliott","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.mayocp.2016.01.002_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mayocp.2016.01.002_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy","volume":"39","author":"Maron","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.mayocp.2016.01.002_bib15","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/01.STR.22.9.1143","article-title":"Ischemic cerebrovascular complications and risk factors in idiopathic hypertrophic subaortic stenosis","volume":"22","author":"Russell","year":"1991","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.mayocp.2016.01.002_bib16","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1161\/01.STR.0000015031.57955.D1","article-title":"Trends in stroke prevalence between 1973 and 1991 in the US population 25 to 74 years of age","volume":"33","author":"Muntner","year":"2002","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.mayocp.2016.01.002_bib17","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1161\/STROKEAHA.113.002936","article-title":"Twenty-year trends in long-term mortality risk in 17,149 survivors of ischemic stroke less than 55 years of age","volume":"44","author":"Giang","year":"2013","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.mayocp.2016.01.002_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/STR.0b013e3181fcb238","article-title":"Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Goldstein","year":"2011","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.mayocp.2016.01.002_bib19","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/hrt.2003.031161","article-title":"Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy","volume":"91","author":"Thaman","year":"2005","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.mayocp.2016.01.002_bib20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.mayocp.2016.01.002_bib21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0002-9149(81)90535-X","article-title":"Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features","volume":"47","author":"McKenna","year":"1981","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.mayocp.2016.01.002_bib22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/eurpub\/ckt076","article-title":"An examination of the association between premature mortality and life expectancy among men in Europe","volume":"24","author":"White","year":"2014","journal-title":"Eur J Public Health"},{"issue":"3","key":"10.1016\/j.mayocp.2016.01.002_bib23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2005.02.090","article-title":"Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy","volume":"46","author":"Ommen","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.mayocp.2016.01.002_bib24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jama.281.7.650","article-title":"Clinical course of hypertrophic cardiomyopathy in a regional United States cohort","volume":"281","author":"Maron","year":"1999","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.mayocp.2016.01.002_bib25","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1161\/01.CIR.92.9.2488","article-title":"Natural history of hypertrophic cardiomyopathy: a population-based study, 1976 through 1990","volume":"92","author":"Cannan","year":"1995","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.mayocp.2016.01.002_bib26","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2005.04.043","article-title":"Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy","volume":"46","author":"Olivotto","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.mayocp.2016.01.002_bib27","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1161\/01.CIR.0000097110.55312.BF","article-title":"Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease","volume":"108","author":"Sorajja","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mayocp.2016.01.002_bib28","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0735-1097(95)00353-3","article-title":"Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population","volume":"26","author":"Cecchi","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2016.01.002_bib29","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(98)00407-0","article-title":"Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death","volume":"32","author":"Haider","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.mayocp.2016.01.002_bib30","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.108.798314","article-title":"Syncope and risk of sudden death in hypertrophic cardiomyopathy","volume":"119","author":"Spirito","year":"2009","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.mayocp.2016.01.002_bib31","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.mayocp.2016.01.002_bib32","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/gim.2013.44","article-title":"Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy","volume":"15","author":"Ingles","year":"2013","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.mayocp.2016.01.002_bib33","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2004.07.045","article-title":"Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy","volume":"44","author":"Van Driest","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2016.01.002_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/heart.90.1.7","article-title":"From malignant mutations to malignant domains: the continuing search for prognostic significance in the mutant genes causing hypertrophic cardiomyopathy","volume":"90","author":"Van Driest","year":"2004","journal-title":"Heart"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619616000215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619616000215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T18:52:35Z","timestamp":1536951155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619616000215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0025619616000215"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2016.01.002","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Natural History of Nonobstructive Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2016.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}